U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07295431) titled 'Sleep Efficacy Randomized Evaluation of a Novel Digital Therapeutic for Insomnia' on Dec. 08.
Brief Summary: This study is a multicenter, randomized, double-blind, sham-controlled clinical investigation designed to evaluate the effectiveness and safety of BELL-001, a digital therapeutic developed to improve symptoms of insomnia. Insomnia is a common sleep disorder that can significantly affect daytime functioning, mood, and overall quality of life. Many patients continue to have difficulties despite lifestyle changes or medication, and safer, non-pharmacological treatment options are increasingly needed.
BELL-001 is a smartphone-ba...